NCT07037732View on ClinicalTrials.gov

Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

January 1, 2030

Study Completion Date

June 1, 2030

Conditions

Autoimmune CytopeniaConnective Tissue DisorderSystemic Vasculitis

Trial Locations (1)

06000

RECRUITING

Chu de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT07037732 - Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders | Biotech Hunter | Biotech Hunter